# clm_C3B4B1FC7983

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: operating_income  
value: 2,079,591,000 United States dollar  
valid_from: 2017-12-31  
valid_to: 2018-12-31  
published: 2018-02-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B9BD4A691253  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals operating income: 2,079,591,000 United States dollar", as of 2017-12-31 (until 2018-12-31). Claim clm_C3B4B1FC7983, https://asof.is/claim/clm_C3B4B1FC7983, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2018-02-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm (primary, SEC EDGAR 10-K FY2017, published 2018-02-08)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 1,330,741,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_C3B4B1FC7983](/claim/clm_C3B4B1FC7983.md) | [clm_1B4689E225C8](/claim/clm_1B4689E225C8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.